A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease: first psychometric approach

The neuropsychiatric symptoms and behavioral disorders affecting Parkinson’s disease (PD) patients are common and disabling. A PD-specific interview-based 12-item scale, the Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease (SEND-PD), has been developed to assess the severity of neuropsychiatric manifestations. The present study is aimed at testing some basic psychometric attributes of this scale. A total of 633  consecutive patients and their caregivers were included in this cross-sectional, multicenter, observational study. In addition to the tested scale, the following assessments were applied: Hoehn and Yahr staging, Scales for Outcomes in Parkinson’s Disease Motor and Psychiatric complications, MiniMental State Examination, Clinical Impression of Severity Index, and the Zarit Caregiver Burden Inventory. Patients in all stages of disease were included and 18.38 % were demented. The SEND-PD was responded by patients (86.16 %), caregivers (13.15 %), or both (0.69 %). Three factors (accounting for 66.63 % of the variance) were identified and considered as subscales: Psychotic symptoms, Mood/Apathy, and Impulse control disorders. The subscales showed satisfactory scaling assumptions (multitrait-item success rate 100 %) and internal consistency (alpha indices >0.70). The convergent validity with other measures of psychiatric symptoms and the discriminant validity to distinguish between categories of patients’ age, duration and severity of disease, and dopaminergic treatment were satisfactory. The precision of the scale dimensions was acceptable. The SEND-PD performed as an acceptable, consistent, valid, and precise scale for evaluation of neuropsychiatric symptoms in Parkinson’s disease.

[1]  David Eidelberg,et al.  Metabolic brain networks associated with cognitive function in Parkinson's disease , 2007, NeuroImage.

[2]  Aj Lees,et al.  Parkinson's disease (vol 373, pg 2055, 2009) , 2009 .

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  H. Groenewegen,et al.  [Impulse control disorders in Parkinson's disease]. , 2011, Tijdschrift voor psychiatrie.

[5]  A. Lees,et al.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.

[6]  K. Dujardin,et al.  Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[7]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[8]  Paolo Barone,et al.  International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  C. McHorney,et al.  Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.

[10]  Paolo Barone,et al.  The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[11]  D. Burn,et al.  Parkinson's disease: The quintessential neuropsychiatric disorder , 2011, Movement disorders : official journal of the Movement Disorder Society.

[12]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[13]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  S. Zarit,et al.  Relatives of the impaired elderly: correlates of feelings of burden. , 1980, The Gerontologist.

[15]  William W. McDonald,et al.  Depression rating scales in Parkinson's disease: Critique and recommendations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[16]  Heleen Beckerman,et al.  Smallest real difference, a link between reproducibility and responsiveness , 2001, Quality of Life Research.

[17]  F. Durif,et al.  Evaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease , 2014 .

[18]  J. Speelman,et al.  Quality of life in patients with Parkinson's disease: development of a questionnaire. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[19]  K. Dujardin,et al.  Anxiety rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[20]  L. Mcgregor,et al.  Measuring components of children's health status. , 1991, Medical care.

[21]  W. Poewe.  Psychosis in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[22]  M Knapp,et al.  Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. , 2005, Health technology assessment.

[23]  F. Micheli,et al.  Cross‐cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages , 2010, Movement disorders : official journal of the Movement Disorder Society.

[24]  Andrew J Lees,et al.  Pathological gambling in Parkinson's disease—a review of the literature , 2011, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[26]  Dagmar Verbaan,et al.  Assessment of psychiatric complications in Parkinson's disease: The SCOPA‐PC , 2007, Movement disorders : official journal of the Movement Disorder Society.

[27]  P. Pollak,et al.  [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease]. , 2009, Revue neurologique.

[28]  Abraham Weizman,et al.  Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. , 1998, Clinical neuropharmacology.

[29]  J. Cummings,et al.  Assessment of Cognitive, Psychiatric, and Behavioral Disturbances in Patients with Dementia: The Neurobehavioral Rating Scale , 1992, Journal of the American Geriatrics Society.

[30]  P. Martínez-Martín,et al.  Scales to measure parkinsonism. , 2007, Handbook of clinical neurology.

[31]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[32]  C. Polman,et al.  Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[34]  D. Aarsland,et al.  Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria. , 2011, Parkinsonism & related disorders.

[35]  S. Leurgans,et al.  Prospective longitudinal assessment of hallucinations in Parkinson’s disease , 2001, Neurology.

[36]  Kathleenl N. Lohr,et al.  Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.

[37]  D. Mash,et al.  Psychotic symptoms in Parkinson's disease. From description to etiology. , 2005, Journal of neurology.

[38]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[39]  J. Steiner,et al.  Health and Quality of Life Outcomes , 2006 .

[40]  W. Ondo,et al.  Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[41]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[42]  P. Rabins,et al.  Prevalence of psychotic symptoms in a community-based Parkinson disease sample. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[43]  J. Benito-León,et al.  The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. , 2005, Journal of clinical epidemiology.

[44]  A. Kishore,et al.  Do nonmotor symptoms in Parkinson's disease differ from normal aging? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[45]  A M Stiggelbout,et al.  A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[46]  M. Stacy,et al.  Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease , 2011, Parkinson's disease.

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[48]  C. Terwee,et al.  Linking measurement error to minimal important change of patient-reported outcomes. , 2009, Journal of clinical epidemiology.

[49]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[50]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.

[51]  Regina Katzenschlager,et al.  Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome , 2004, Movement disorders : official journal of the Movement Disorder Society.

[52]  C. Bombardier,et al.  A taxonomy for responsiveness. , 2001, Journal of clinical epidemiology.

[53]  Pablo Martínez-Martín,et al.  Global versus factor‐related impression of severity in Parkinson's disease: A new clinimetric index (CISI‐PD) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[54]  W. Oertel,et al.  Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. , 2005, Journal of neurology.

[55]  W. Weiner,et al.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease. , 2002, Parkinsonism & related disorders.

[56]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[57]  W. Poewe,et al.  Scales to assess psychosis in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[58]  Dagmar Verbaan,et al.  Non-motor symptoms in Parkinson's disease , 2009 .

[59]  P. Martínez-Martín,et al.  The clinical impression of severity index for Parkinson's disease: International validation study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[60]  Pablo Martinez-Martin,et al.  Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.

[61]  P. Moberg,et al.  Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.

[62]  M. Sordo,et al.  Caregiver burden in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[63]  John Hardy,et al.  Parkinson's disease , 2009, The Lancet.

[64]  J. Benito-León,et al.  Health‐related quality of life evaluation by proxy in Parkinson's disease: Approach using PDQ‐8 and EuroQoL‐5D , 2004, Movement disorders : official journal of the Movement Disorder Society.

[65]  A. Lang,et al.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.

[66]  Daniel Weintraub,et al.  Psychiatric complications in Parkinson disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[67]  R. Hays,et al.  Psychometric considerations in evaluating health-related quality of life measures , 1993, Quality of Life Research.